Testosterone Replacement Therapy | Department of Urology

Dr. Raymond Costabile and Dr. Ryan Smith specialize in the diagnosis and treatment of low testosterone.

Hypogonadism, also known as low testosterone or low T, can lead to symptoms of decreased energy and libido, difficulty building lean muscle mass, moodiness, difficulty concentrating, and even loss of bone density. Men who have some or all of these symptoms and demonstrate low testosterone on a blood draw are candidates for testosterone replacement therapy (TRT).

There are many options for TRT, each of which has its benefits and disadvantages. The decision about which one is right for you will depend on your personal preferences and a discussion with your doctor. In some cases, different insurance companies may cover one option and not another, which may also be taken into consideration. If the desired effects are not achieved with your initial choice, a different option can be tried to see if it is a better fit for you, your health, and your lifestyle.

Regardless of the type of testosterone replacement therapy chosen, you will need to first be evaluated by your doctor and then monitored at regular intervals (usually every 3-6 months) to confirm good control of your hypogonadal symptoms, check levels of testosterone and perform other related bloodwork, and to ensure that there are no potentially dangerous side effects.

The evaluation and follow-up regimen usually consists of the following:

Read the rest here:
Testosterone Replacement Therapy | Department of Urology

Testosterone Replacement Therapy Vivacity Clinic of Las …

The medical community agrees that testosterone begins to decline gradually in most men by the time they reach the age of 30. If left unchecked, testosterone levels will continue to decline as you age, meaning that the average 50-year-old will have far less testosterone than the average 35-year-old, even though individuals are in a state of testosterone decline.

The effects of diminishing testosterone should be hardly noticeable for most men in their 30s. Once you hit 50, however, the effects may truly start to set in. Your sex drive may be reduced, you may have difficulty getting or maintaining an erection, your overall mood and energy may drop, and you may feel symptoms of irritability and even depression. Fortunately, the availability of testosterone replacement therapies for men over 50 means that you can break this cycle and regain at least some of the vitality you possessed as a young man.

VCLV Testosterone Replacement Therapy (TRT)offers physician prescribed and medically supervised Testosterone Therapy programs helping patients enter a cost effective and comprehensive Low Testosterone Treatment program designed to treat adult men over the age of 35 suffering from symptoms and problems associated with Low-T,hypogonadism and andropause also known as "male menopause".

Testosterone Replacement Therapy (TRT) with injectable testosterone, testosterone cream or gel can help men with low testosterone levels. Testosterone treatment is carefully formulated to help alleviate symptoms due to male menopause - Low T.

Treat low testosterone symptoms: loss of energy; low sex drive; erectile dysfunction; loss of muscle tone; irritability; depression; insomnia, feeling tired all the time bordering on fatigue; loss of focus and drive.

See the original post here:
Testosterone Replacement Therapy Vivacity Clinic of Las ...

Testosterone Replacement Therapy in Ashburn, VA

As men age, they notice a change in their physical and mental states. This change stems from the body's lowered testosterone production. Decreased libido,depression and many more side-effects can be caused by low testosterone.

The symptoms of low testosterone are sometimes referred to as Andropause. Andropause can seem like a dead end, a condition with no solution. Due to today's advanced medical technology, that isn't the case. Testosterone replacement therapy can provide relief; to get started please call (703) 327-2434 or contact Virginia Center for Health & Wellness online.

While most people associate low testosterone with men in their 60's, it can occur in men as young as 35. Before deciding if testosterone replacement therapy is what you need, it's important that you identify the signs of andropause. Andropause can cause:

These signs may appear all at once or one at a time. The onset of low testosterone, referred to as Low-T, can be sudden and shocking. Men's testosterone levels gradually decline as they age, making most men over 50 an ideal candidate for testosterone replacement therapy.

While it's most commonly caused by age, Low-T can also stem from:

To determine if you are suffering from Low-T, your doctor can administer a testosterone level test. This usually occurs in the form of a simple blood test. To schedule such a test, please call (703) 327-2434 or contact Virginia Center for Health & Wellness online.

Low testosterone is best treated with testosterone replacement therapy. This treatment is a form of hormone replacement therapy, or HRT. In essence, HRT rejuvenates your system by replenishing your depleted testosterone levels.

Conventional HRT makes use of synthetic hormones that are potentially damaging to your system. This makes bioidentical hormone replacement therapy (BHRT) the preferred form of testosterone replacement treatment.

BHRT uses testosterone that is chemically and biologically identical to that your body produces naturally. This makes BHRT both safer and more effective than traditional hormone replacement therapy.

Bioidentical testosterone can be delivered in a number of ways, including:

Each of these methods is a viable way to boost your testosterone levels and combat Low-T.

The only way to feel like a young man again is with testosterone replacement therapy, and the only way to receive this BHRT is from an experienced professional. If you're curious about testosterone hormone replacement therapy, you need to schedule a consultation. Please call (703) 327-2434 or contact Virginia Center for Health & Wellness online.

Read more from the original source:
Testosterone Replacement Therapy in Ashburn, VA

Testosterone Replacement Therapy – Renue Health

Testosterone is a hormone that is present in both men and women. Testosterone is the androgenic hormone primarily responsible for normal growth and development of male sex and reproductive organs, including the penis, testicles, scrotum, prostate, and seminal vesicles. It facilitates the development of secondary male sex characteristics such as musculature, bone mass, fat distribution, hair patterns, laryngeal enlargement, and vocal chord thickening. Additionally, normal testosterone levels maintain energy level, healthy mood, fertility, and sexual desire.

The number of men diagnosed with hypogonadism, commonly referred to as Low T has grown dramatically in recent years due to an increasing awareness of the importance of hormones in a mans health and well being. Research shows that about 1 out of 4 men over the age of 30 may have low testosterone. Circulating testosterone levels decline progressively with age, starting in the second and third decade of life. Testing for testosterone deficiency requires a comprehensive understanding of the intricacies of hormone balance before one makes a commitment to what may be lifelong therapy.

Low Libido

Gaining fat around the middle

If you have any of these common symptoms, it is recommended you have a proper and thorough set of labs drawnto help determine if you havehypogonadism.

Testosterone replacement therapy is essential for men with hypogonadism. In these men, full replacement of testosterone is necessary. The amount of total testosterone in men can range from 300 to 1100 ng/ml, while the range for free testosterone is 50 to 250 ng/ml. It is more accurate to utilize free testosterone levels instead of total T levels.

Because the range is so broad, testosterone optimization must be individualized. In general, Dr. Rob aims to provide the lowest dose of testosterone that relieves symptoms and causes the man to be in the optimized zone. All while monitoring testosterone and its by-products for any potential unwanted side effects. There are several delivery method options and Dr. Rob presents the pros and cons of each before a mutually agreed upon delivery method is instituted.

It is also important to note that men should not be started on testosterone replacement without a careful endocrine evaluation to determine the cause of the low testosterone. Serious conditions including pituitary tumors can present with low testosterone.

Women have testosterone too

Men have 10 to 20 times higher levels of testosterone than women. Nonetheless, even this small amount of testosterone in women is important for maintaining sexual function, and healthy bladder and vaginal function.

When used in small physiologic doses with monitoring of testosterone blood levels, testosterone in women is well tolerated. High doses must be avoided as they can cause facial hair, loss of scalp hair, deepening of voice, and acne. Just like men, womenshould not be started on testosterone replacement without a careful endocrine evaluation to determine if it will provide a health benefit.

ReNue Healthis located conveniently in Springboro, Ohio with easy access from Dayton International Airport, Cincinnati International Airport or the adjacent Wright Brothers Private Airport (MGY) for those travelling by private aviation.Click here for directions and contact information.

Only one visit is necessary to perform a comprehensive history, interview, and education. Follow up evaluations, adjustments and balancing of hormones are done by phone or written communications and a return visit to Dr. Rob is not necessary. Ongoing testing and adjustment is mandatory and performed through a laboratory convenient to your home.

Its that nagging feeling that something does not feel quite right and you cant put your finger on it. Youre a busy person and your own health is the last thing you have time to think about, but think again!

To learn how the ReNue Health Opportunity may help restore your youth and vitality, simply call937-350-5527or visit us online atwww.renuehealth.com

More here:
Testosterone Replacement Therapy - Renue Health

Testosterone Replacement Portland – Testosterone Therapy …

Similar to women, men also experience a hormonal decline as they age. Testosterone levels usually peak between the ages of 18-25 and then it gradually declines at a rate of about one percent per year thereafter.

Known as andropause, the decline of testosterone levels can make daily life a struggle. However, unlike menopause, the symptoms of andropause are subtle. An increase in daytime fatigue and decreased sexual interest are usually the first signs that hormones are shifting. Other symptoms may include weight gain, fatigue, muscle loss, depression, memory loss, decreased drive, erectile dysfunction, decreased sex drive, and irritability.

Your customized treatment plan may consist of the integration of testosterone replacement, thyroid support, DHEA replacement, nutrition, exercise, and nutritional supplements. With optimal levels of testosterone, the body becomes strong again by building lean muscle and supporting healthy heart and brain function. By optimizing testosterone, you may experience:

Bio-identical testosterone pellet therapy is a natural alternative to synthetic testosterone that offers sustained daily testosterone levels for up to 3-6 months. Unlike testosterone injections, creams, gels, and patches, which usually cause a roller coaster effect of testosterone blood levels, testosterone pellets offer a steady dose.

If you live in the area of Portland, including Beaverton, Lake Oswego, Tigard, Milwaukie, Clackamas, Oregon City, Tualatin, Wilsonville, Hillsboro, Sherwood and Vancouver, and want to feel your best as you age, Dr. Maddox has the knowledge and experience in testosterone replacement therapy to help you. Contact us today to schedule your consultation and take back control of your health.

September 2015

See the original post:
Testosterone Replacement Portland - Testosterone Therapy ...

Testosterone Replacement | T Nation

Testosterone replacement is an issue that concerns most men over the age of 35 or 40. Although these men may feel great, they know, deep down, that they feel differently than when they were in their twenties. Granted, a lot of it has to do with general wear and tear and a host of age-related declines, but some of it has to do with the steady decline in testosterone production.

Few men take advantage of testosterone replacement, though. Either they accept all of the propaganda perpetuated by the media and the various health-care practitioners who haven't bothered to bone up on the subject, or they just don't know enough about it.

This article may give you the info that you need to pursue this avenue. True, most of the research on the subject concerns men who need total testosterone replacement. But the information still applies to those who are clinically deficient and need only a little boost to regain the sexual staying power and the muscle-building ability that they had in their twenties.

Hey, you with the bulge in your pants...yeah, you. Been feeling a little hornier than usual lately? Have you found yourself passing trees and musing about how like a young girl's legs the limbs are, and how inviting that knothole in the crotch is, if only that woodpecker would fly the hell away? Does everything with a hole in it, whether it be a doughnut or a soap-on-a-rope, conjure up amorous fantasies?

C'mon, you can level with ol' TC. You've even been eyeing that pumpkin on the stoop, haven't you? That eye socket looks so moist, so inviting and, come Monday, the day after Halloween, that bitch is gonna' be yours...

Ahh, but who can blame you? It's October, and the testosterone levels of the North American male are up way up this time of year. Like other animals, homo sapiens have circannual variations in testosterone production as much as 25%, depending on the time of year. October, at least according to one group of researchers (Smals, et al., 1976), is the month, while other researchers (Dabbs, 1990) think that we get a little hornier in December.

Regardless of the exact month, most of us seem to be having a lot of trouble focusing on things lately. But some of us aren't having any trouble focusing at all. Some men, because of advancing age or assorted medical problems, have low testosterone. It may not be an issue for you...yet. But sooner or later, your T levels will begin to drop, as surely as the value of my stock portfolio dropped when I invested in Ian King's new signature line of industrial-strength panty shields.

Being able to focus on things a little better is probably a plus. But when you weigh that small advantage against all the other side effects of low testosterone, lack of concentration seems to be an appealing alternative. Consider the following symptoms of low T:

Decreased bone mass Skin atrophy, along with paleness and fine wrinkles Anemia Muscle atrophy Erectile dysfunction Decrease in sperm count Decrease in volume of ejaculate Decrease in libido Shrinkage and softening of the testes Disappearance of spontaneous erections Prostate shrinkage (below normal)

Now, I really think that Tribex-500 can boost T levels and help stave off that age-related decline, but it's probably never going to take the place of various pharmaceutical testosterone preparations.

As far as the medical community is concerned, the goal of T replacement is to get levels as close to physiologic concentrations as possible. We at T pretty much agree with that, but we'd like to see docs push the envelope a bit and get all of us close to high normal, but no matter.

In the beginning of the whole science of T replacement, only the basic esters of testosterone were all based on the real thing. Then, scientists started to tinker with testosterone, trying to make it better. Basically, there were three roads that they could take: work on different routes of administration, chemical modification of the molecule itself, or esterification in the 17-beta position of the T molecule.

Ever wonder why you can't just drink T down instead of shooting it into a butt cheek? Contrary to popular belief, you can actually drink most injectable steroids. Testosterone is absorbed pretty well from the gut, but the liver grabs a hold of the stuff, metabolizes it, and inactivates it before it gets to the target organs. This phenomenon is known as the "first pass effect."

Only when the dosage exceeds 200 mg which is about 30 times the amount produced daily in normal, healthy man is the liver outgunned. Of course, if you were suffering from total testicular shutdown, you'd have to suck down 400-600 mg a day to see any positive effects. That, of course, aside from causing some potential health problems, would force you to hock your Beemer.

Unfortunately, you still see stuff in health food stores that contains dried up animal testis. Now, eating these things like popcorn kernels could theoretically work, but there's another problem: unlike other endocrine glands, the testes don't contain a lot of stored up hormone, so eating hundreds of them wouldn't do any good anyhow. Makes you wonder how they can still sell these extracts, doesn't it?

In an effort to thwart this first pass effect and produce "edible" steroids, scientists started making synthetic forms that were alkylated at the 17-alpha position of the molecule. In essence, that protected them from the metabolizing effects of the liver. The trouble is that these are the steroids that give steroids a bad rap. They cause toxic side effects such as elevated liver enzymes, cholestasis (a stoppage of bile flow), and peliosis (the presence of blood-filled cysts in the liver). These drugs have also been implicated in liver tumors.

Synthetic forms had other problems, too. Trouble was, these synthetic forms didn't duplicate all the actions of T. For instance, some of them didn't convert to 5-alpha DHT or estrogen and, despite the bad press that both of these compounds get, they're vital to normal human function.

That's why doctors don't typically prescribe anything else other than "natural" forms of T. After all, the stuff's been used for over six decades and has one of the highest safety records of any drug. There will probably be exceptions in the future, though. For instance, 7 alpha-methyl-19-nortestosterone (MENT) is experiencing a kind of renaissance, since it has high androgenecity and low growth-promoting effects on the prostate. Likewise, researchers continue to look at testosterone undeconoate. Unlike other "designer" steroids, this drug was esterified in the 17-beta position. It has virtually none of the side effects of the 17-alpha drugs, but it has such a short half-life that it ought to be prescribed in a Donald Duck Pez dispenser.

After pretty much settling on natural testosterone as the best hormonal thing since the invention of sliced hormonal bread, researchers started monkeying around with delivery systems. One relatively new delivery system involves incorporating T into cyclodextrins. When they're administered orally, you get a T spike that lasts about the length of an average feature-length movie. In order for it to do any good, you'd have to remember to pop some in your mouth several times a day. Consequently, this type of delivery system's pretty much been tossed out with yesterday's chicken salad. Interestingly, a lot of supplement companies have adopted this delivery system for use with their androstenedione products. A nice idea but, again, the spike is very short-lived and very uneven.

Another delivery system that never achieved widespread popularity (outside of San Francisco) is rectal administration, via suppository. Too bad, too, because it works pretty well. You avoid the first pass effect, and a dose of only 40 mg can cause a boost in serum T that lasts about four hours. Nasal application has also been investigated. You can avoid the first pass effect this way, too, but the effects are unreliable and short-lived. Besides, one sneeze, and you've got snot and steroids on your sleeve.

There was recently some work done with microspheres in which tiny, time-release chemical nuggets were injected directly into the bloodstream. A dosage of just 315 mg raised T levels gradually to a peak over the course of eight weeks, then gradually reaching sub-clinical levels after eleven weeks. Again, the method had its problems. The spheres lacked stability and were hard to make. No one's really done any work with them since '96 (Bhasin and Swerdloff).

Rod-shaped implants, similar to the Norplant birth-control implants used by some women, are experiencing renewed interest. These things exert their effects for several weeks or months. Along the same lines, actual testes-shaped implants are available, too. They consist of about 10 grams of vinyl and about 6.4 grams of T. Once implanted in the scrotal sac, they keep T levels normal for about a year. Obviously, the use of these is problematic, unless you're missing a nut or don' t mind having a third. Maybe an alternative would be to put them just under the skin over the biceps so that the patient can have instant Robbie Robinson-like biceps peaks.

One method that's in widespread use is the patch. Even though putting one on in the morning and taking it off the next morning produces a great pharmokinetic profile (with fairly natural rises and falls in T), the patch has its problems. For one thing, it's hard to control absorption rates. Scrotal skin is the thinnest and easiest to permeate and has an absorption rate that's about 40 times higher than the forearm. Other areas work, but you have to use an alcoholic enhancer, which makes skin reactions more probable.

And, a slightly bizarre problem one that few people even considered a few years ago was person-to-person transfer. Just hugging a spouse or child is enough to androgenize them, leading to masculine traits in the female or premature sexual development in children.

Unfortunately for needle-phobics everywhere, it seems that needles are around to stay at least for the time being as intramuscular delivery elicits the fewest number of side effects or problems. Currently, there are three common testosterone esters used in T replacement therapy:

Testosterone propionate Testosterone cypionate Testosterone enanthate

For complete T replacement, testosterone propionate must be injected every two to three days, while enanthate requires a shot of 200-250 mg every two weeks. This dosage is, of course, for total T replacement, and partial T replacement would require much less. One other testosterone ester, testosterone cyclohexanecarboxyate, has similar properties but is less widely used that the other three.

Given the shortcomings of intramuscular T therapy (a big spike in the beginning, followed by a gradual decline) and all of the shortcomings of the various preparations and delivery systems, the World Health Organization initiated a steroid synthesis program in 1980 to develop different types of steroids. As far as I can tell, they didn't make too much headway. But they did develop testosterone buciclate, a single shot (600 mg) of which produced normal T levels in hypogonadal men for 12 weeks. This stuff will probably be made available in a year or two.

And the Chinese found that testosterone undeconoate, when dissolved in teaseed oil and used intramuscularly (instead of swallowed as a capsule), produced pharmacological effects similar to testosterone enanthate. Later studies used castor oil instead of teaseed oil and found that a 1,000-mg shot had effects lasting as long as eight weeks. Whether or not this will catch on as the testosterone replacement drug of choice remains to be seen.

Generally, good things happen after T therapy begins. Abdominal fat generally goes down, muscle mass goes up, and all of the "bad" symptoms of low T go bye-bye. Other inconsequential things happen, too. For instance, beard growth and frequency of shaving goes up. Interestingly, giving total T replacement to a hypogonadal man will affect his hairline, too. Now, I'm not talking about baldness necessarily, but the actual front hairline which, in women or children or men with virtually no T, stretches straight across the forehead. Once T levels rise, though, recession around the temples occurs.

Baldness, of course, is a possibility in those genetically predisposed to the condition.

Sebum production goes up, too, so you can go through that whole adolescent acne thing all over again. Gynecomastia may also become a problem, but that can usually be handled just by adjusting dosages or switching preparations. Additionally, there are several prescription-type aromatase inhibitors that may be used to fight the problem (interestingly, these aromatase inhibitors themselves might be used to raise T production we'll have an article on nonprescription forms of aromatase inhibitors in the next week or two).

This may surprise you, but virtually nothing bad happens after T replacement therapy begins, at least not in the vast majority of patients. No negative side effects occur to the liver (remember, all the bad things took place as a result of using the 17-alpha alkylated stuff you generally get from dealers or overseas markets). No definite negative cardiovascular effects have been noted. Even the prostate, long regarded as the first organ to take the plunge after using "evil" steroids, is relatively safe. The truth is that it's pretty much accepted now that prostate growth occurs through the action of 5-alpha DHT and that these effects are related to things that happen exclusively within the prostate and are not influenced by serum concentrations of T or 5-alpha DHT. Furthermore, estrogens are believed to be the true culprit by some. T therapy increases the prostate size slightly, but only to the point of normalcy. If any doubt of this remains, a recent study (Hajjar, 1997) tracked men in their seventies who had been receiving T replacement therapy for two years. The treatment group experienced less prostate growth than the control group.

In fact, the only possible problem seen with T therapy is an occasional rise in red blood cell count (hematocrit) which, if unchecked, could contribute to stroke or cardiovascular episodes of some kind. In those cases, either the dosage was adjusted or the patient was asked to donate an occasional pint of blood.

In fact, it was the conclusion of one pair of authors (Nieschlag and Behre, 1999) that "...there is no proof that testosterone is a life-shortening agent. The risks inherent to testosterone, be it of endogenous or exogenous origin, would then appear to be the tribute men have to pay for being men."

Couldn't have said it better myself.

Original post:
Testosterone Replacement | T Nation

From Wellness and Prevention to Testosterone Replacement Therapy – Video


From Wellness and Prevention to Testosterone Replacement Therapy
From Wellness and Prevention to Testosterone Replacement Therapy Joel Heidelbaugh, MD Get this presentation and more like it at http://www.fleetwoodonsite.com/a4m Recorded at the A4M ...

By: FleetwoodOnsite

Continued here:
From Wellness and Prevention to Testosterone Replacement Therapy - Video

testosterone replacement therapy online | Find a testosterone replacement therapy online – Video


testosterone replacement therapy online | Find a testosterone replacement therapy online
testosterone replacement therapy online | Find a testosterone replacement therapy online Do you know the A number of00 Testosterone Replacement Therapy Obtai...

By: testosterone replacement therapy online

Read the original post:
testosterone replacement therapy online | Find a testosterone replacement therapy online - Video

CAN MY WIFE GET PREGNANT if I’m on Testosterone Replacement Therapy? – Video


CAN MY WIFE GET PREGNANT if I #39;m on Testosterone Replacement Therapy?
Jim, a long time subscriber, wants to know if he can give up birth control with his wife now that he is on testosterone replacement therapy? Thats a real good question Jim.....lets talk about...

By: bignoknow

Continued here:
CAN MY WIFE GET PREGNANT if I'm on Testosterone Replacement Therapy? - Video

Atlanta Testosterone Replacement Therapy Clinics – Video


Atlanta Testosterone Replacement Therapy Clinics
Atlanta Testosterone Therapy Clinics http://lowtsymptoms.net Low Testosterone Symptoms can cause havoc with a man #39;s physique. Testosterone is the "high octane" fuel that drives a man #39;s sexual...

By: Atlanta Testosterone Replacement Therapy

View original post here:
Atlanta Testosterone Replacement Therapy Clinics - Video

Testosterone Lawsuit | AndroGel, Testim, Axiron, Bio-T-Gel – Video


Testosterone Lawsuit | AndroGel, Testim, Axiron, Bio-T-Gel
If you suffered heart problems after using a testosterone gel or cream as part of testosterone replacement therapy treatment, please contact The Cochran Firm at 202-682-5800 to receive a free,...

By: David Haynes

See the original post here:
Testosterone Lawsuit | AndroGel, Testim, Axiron, Bio-T-Gel - Video

Global Testosterone Replacement Therapy Market Forecast, by regions, type and application, with sales and revenue, from 2019 to 2024. – Med News…

According to a latest report published by Global Marketers Biz named as Testosterone Replacement Therapy Market offers data for the forecast period 2019-2024. A comprehensive research updates and data which includes following key aspects for the global Testosterone Replacement Therapy Market in terms of volume and revenue Visitor Demographics, Facility Size, Demand & Growth Opportunities, Global Industry Forecast Analysis and Revenue Source.

The Testosterone Replacement Therapy Market report offers in-depth analysis and insights into developments impacting businesses and enterprises on global & regional level. A detailed breakdown of key trends, drivers, restraints, and opportunities influencing revenue growth is presented in this research report. This study focuses on the global Testosterone Replacement Therapy market by share, volume, value, and regional appearance along with the types and applications.

Request a free sample report on Testosterone Replacement Therapy market @https://www.globalmarketers.biz/report/life-sciences/global-testosterone-replacement-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/129647#request_sample

Please Note :This Report can be dispatched within 24 Hours

Key Players of Testosterone Replacement Therapy Report are:

AbbVieEndo InternationalEli lillyPfizerActavis (Allergan)BayerNovartisTevaMylanUpsher-SmithFerring PharmaceuticalsKyowa KirinAcerus Pharmaceuticals

Market is Segmented into below points:

Market by Type/Products:

GelsInjectionsPatchesOther

Market by Application/End-Use:

HospitalsClinicsOthers

Market by Region:

For Discount on this report please visit @ https://www.globalmarketers.biz/report/life-sciences/global-testosterone-replacement-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/129647#inquiry_before_buying

Some of the major areas of this report:

Request for Customized Report:https://www.globalmarketers.biz/report/life-sciences/global-testosterone-replacement-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/129647#inquiry_before_buying

About Global Marketers Biz:

Global Marketers is a research eye which discovers the syndicate, custom and consulting research needs. The company surpasses in catering to the research requirements of commercial, industrial and all other business enterprises. Surgical market analysis followed by Comprehensive research methodology will drive the businesses in planning & reshaping the business schemes and the growth of industry. The company also offers research reports related to chemical, healthcare, technology, automobile and several other sectors. This is the trustworthy brand when talked about quality survey and highly reachable to customer requirements of any industry situated across the globe.

For any additional questions get in touch with,

Mr. Alex White

Email: alex@globalmarketers.biz

Phone number: +1(617)2752538

Website: https://www.globalmarketers.biz/

Follow this link:
Global Testosterone Replacement Therapy Market Forecast, by regions, type and application, with sales and revenue, from 2019 to 2024. - Med News...

LPCN LOSSES ALERT: Bernstein Liebhard LLP Reminds Investors of Its Investigation of Lipocine Inc – Yahoo Finance

NEW YORK, NY / ACCESSWIRE / November 11, 2019 / Bernstein Liebhard, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of Lipocine Inc. ("Lipocine" or the "Company") (LPCN) resulting from allegations that Lipocine might have issued misleading information to the investing public.

If you purchased Lipocine securities, and/or would like to discuss your legal rights and options please visit LPCN Shareholder Investigation or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.

On November 11, 2019, Lipocine announced that it had received a Complete Response Letter ("CRL") from the U.S. Food and Drug Administration regarding its New Drug Application for TLANDO, Lipocine's product candidate for testosterone replacement therapy. Lipocine advised investors, among other things, that "[t]he CRL identified one deficiency stating the efficacy trial did not meet the three secondary endpoints for maximal testosterone concentrations." On this news, Lipocine's stock price fell sharply during trading on November 11, 2019.

If you purchased Lipocine securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/lipocineinc-lpcn-shareholder-class-action-lawsuit-stock-fraud-218/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. 2019 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:Matthew E. GuarneroBernstein Liebhard LLPhttp://www.bernlieb.com(877) 779-1414MGuarnero@bernlieb.com

SOURCE: Bernstein Liebhard LLP

View source version on accesswire.com: https://www.accesswire.com/566097/LPCN-LOSSES-ALERT-Bernstein-Liebhard-LLP-Reminds-Investors-of-Its-Investigation-of-Lipocine-Inc

Link:
LPCN LOSSES ALERT: Bernstein Liebhard LLP Reminds Investors of Its Investigation of Lipocine Inc - Yahoo Finance

Pomerantz Law Firm Announces the Filing of a Class Action against Lipocine Inc. and Certain Officers LPCN – GlobeNewswire

NEW YORK, Nov. 15, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP announce that a class action lawsuit has been filed against Lipocine Inc. (Lipocine or the Company) (NASDAQ:LPCN) and certain of its officers. The class action, filed in United States District Court, for the District of Utah, and docketed under 19-cv-00906, is on behalf of a class consisting of investors who purchased or otherwise acquired Lipocine securities between March 27, 2019, and November 8, 2019, both dates inclusive (the Class Period), seeking to recover damages caused by Defendants violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the Exchange Act) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

If you are a shareholder who purchased Lipocine common shares within the Class Period, you have until January 14, 2020, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at http://www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

[Click here for information about joining the class action]

Lipocine is a specialty pharmaceutical company that focuses on the development of pharmaceutical products in the area of mens and womens health. The Companys primary development programs are based on oral delivery solutions for poorly bioavailable drugs. The Company has a portfolio of product candidates purportedly designed to produce pharmacokinetic characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability.

Lipocines lead product candidate is TLANDO (LPCN 1021), an oral testosterone replacement therapy. The Company has previously submitted New Drug Applications (NDA) for TLANDO twice and, both times, received Complete Response Letters (CRL) from the U.S. Food and Drug Administration (FDA) rejecting the NDAs. The Company received the first CRL in June 2016 and the second in May 2018.

On March 27, 2019, during pre-market hours, Lipocine issued a press release announcing new topline results from a study evaluating TLANDOs effects on blood pressure (one issue cited by the FDA in a prior CRL rejecting TLANDOs NDA), as well as the Companys intention to refile the NDA for TLANDO in the second quarter of 2019 (the March 2019 Press Release).

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) the results from Lipocines clinical studies of TLANDO were insufficient to demonstrate the drugs efficacy; (ii) accordingly, Lipocines third NDA for TLANDO was highly likely to be found deficient by the FDA; and (iii) as a result, the Companys public statements were materially false and misleading at all relevant times.

On November 11, 2019, Lipocine issued a press release announcing receipt of a CRL from the FDA regarding its NDA for TLANDO. In the press release, Lipocine advised investors that the FDA had again rejected the NDA for TLANDOthis time because an efficacy trial had not met three of its secondary endpoints.

On this news, Lipocines stock price fell $1.93 per share, or 70.7%, to close at $0.80 per share on November 11, 2019.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See http://www.pomerantzlaw.com.

CONTACT:Robert S. WilloughbyPomerantz LLPrswilloughby@pomlaw.com

View post:
Pomerantz Law Firm Announces the Filing of a Class Action against Lipocine Inc. and Certain Officers LPCN - GlobeNewswire

Testosterone Replacement Therapy Market by application, Outlook and forecast 2019-2027 – Crypto Journal

The Testosterone Replacement Therapy Market Report is a valuable source of information for corporate strategists. This study contains comprehensive data that enhances the understanding, scope and application of this report. The report contains all the necessary information about the latest innovations, such as: For example, Porters five-pot model analysis and advanced profiles of elite industry participants.

The major players in the Testosterone Replacement Therapy Market investigated in this report are: AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer, Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc.

Request a sample copy of this report @ https://www.coherentmarketinsights.com/insight/request-sample/2024

In the developing Markets of the Asia-Pacific, the Middle East, China, India, Japan and Australia, increased development prospects are to be expected due to the enormous potential in the individual countries. The various industry trends and threat factors are carefully examined and described in detail in this Testosterone Replacement Therapy report.

The study will also highlight the industrys key players, their product, business portfolio, Market share, financial status, regional share, segment sales, SWOT analysis, key strategies including mergers and acquisitions, product developments, joint ventures and partnerships, as well as improvements to their latest news.

In addition, this study will help our customers solve the following problems:

Cyclical Dynamics We forecast the dynamics of the industry through analytical and unconventional Market research approaches. Our customers use the information we provide to navigate Market uncertainty and disruption

Identifying Cannibalization Keys A major replacement for a product or service is the most common threat. Our customers can use our research findings to identify an important cannibalization of a Market. This helps them to prioritize their strategies for developing / delivering new products

Recognizing Emerging Trends Our range of ecosystems helps clients identify current Market trends. We also track possible impacts and disruptions that a Market would experience through a particular emerging trend. Our proactive analysis helps clients benefit from early intervention

Associated Opportunities With this report, customers can make decisions based on data, which increases the likelihood that the strategies in the real world will perform better, if not the best

For more information, see Download PDF Copy Here @ https://www.coherentmarketinsights.com/insight/request-pdf/2024

This study addresses some of the issues listed below:

How big is the Testosterone Replacement Therapy Market worldwide?

Which screen size is most preferred by consumers of Testosterone Replacement Therapy?

What type of distribution channel is most preferred by the producers of Testosterone Replacement Therapy?

What is the preferred age group for forwarding Testosterone Replacement Therapy to manufacturers?

What are the key factors that inhibit the growth of the Market, and to what extent are these factors affecting drivers and restraint systems?

How are the regulations affecting the growth of the Testosterone Replacement Therapy Market?

Which is the leading region / country for the growth of the Market? What is the expected growth rate of the leading regions in the forecasting period?

How will the emerging Testosterone Replacement Therapy Market develop in the coming years? How should the consumption pattern develop in the future?

Who are the main players in the global Testosterone Replacement Therapy Market? What is the current Market position of the key players? Who are the emerging players in this industry?

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Name: Mr. Raj Shah

Phone: US +12067016702 / UK +4402081334027

Email: [emailprotected]

Visit our Blog: https://hospitalhealthcareblog.wordpress.com/

Read the original:
Testosterone Replacement Therapy Market by application, Outlook and forecast 2019-2027 - Crypto Journal

Testosterone Replacement Therapy Market 2019 to 2024 With Top Countries Data : Opportunities, Industry Trends and Policies by Regions and Companies -…

The worldwide market for Testosterone Replacement Therapy is expected to grow at a CAGR of roughly -4.2% over the next five years, will reach 1410 million US$ in 2024, from 1820 million US$ in 2019, according to a new Reserach Report

Testosterone Replacement Therapy Market2019 Research report contains a qualified and in-depth examination of Testosterone Replacement Therapy Market. At first, the report provides the current Testosterone Replacement Therapy business situation along with a valid assessment of the Testosterone Replacement Therapy business. Testosterone Replacement Therapy report is partitioned based on driving Testosterone Replacement Therapy players, application and regions. The progressing Testosterone Replacement Therapy economic situations are additionally discovered in the report.

Short Description About Testosterone Replacement Therapy Market :

Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.

Get Sample PDF of reporthttps://www.360researchreports.com/enquiry/request-sample/13836798

The research covers the current market size of the Testosterone Replacement Therapy market and its growth rates based on 5-year records with company outline ofKey players/manufacturers:

Scope Of The Report :

Testosterone deficiency, also referred to as hypogonadism, is a common problem among men aged between 40 and 79 years, with some studies stating that nearly 30% of all men worldwide are affected by hypogonadism. As the incidence of testosterone deficiency increases, it is expected that the demand for TRT will also show a simultaneous increase.The global average price of testosterone replacement therapy is in the decreasing trend, from 45.4 USD/Unit in 2012 to 34.9 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.The classification of testosterone replacement therapy includes gels, injections, patches and other types, and the proportion of gels in 2016 is about 72%.Testosterone replacement therapy is widely sold in hospitals, clinics and other field. The most proportion of testosterone replacement therapy is sold in clinics, and the consumption proportion is about 43%.North America region is the largest supplier of testosterone replacement therapy, with a production market share nearly 86% in 2016. Europe is the second largest supplier of Testosterone Replacement Therapy, enjoying production market share nearly 9.9% in 2016.North America is the largest consumption place, with a consumption market share nearly 83% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 12%. Market competition is intense. AbbVie, Endo International, Eli Lilly, Pfizer, Actavis (Allergan)Bayer, etc. are the leaders of the industry. The top five players together held about 80% of the market in the same year and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. The worldwide market for Testosterone Replacement Therapy is expected to grow at a CAGR of roughly -4.2% over the next five years, will reach 1410 million US$ in 2024, from 1820 million US$ in 2019, according to a new research study.This report focuses on the Testosterone Replacement Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Inquire more and share questions if any before the purchase on this report at https://www.360researchreports.com/enquiry/pre-order-enquiry/13836798

Report further studies the Testosterone Replacement Therapy market development status and future trend across the world. Also, it splits Testosterone Replacement Therapy market by Type and by Applications to fully and deeply research and reveal market profile and prospects.

Major Classifications are as follows:

Major Applications are as follows:

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Testosterone Replacement Therapy in these regions, from 2014 to 2024, covering

The Testosterone Replacement Therapy market report provides answers to the following key questions:

Purchase this report (Price 3480 USD for a single-user license) https://www.360researchreports.com/purchase/13836798

Major Points from Table of Contents:

1 Market Overview1.1 Testosterone Replacement Therapy Introduction1.2 Market Analysis by Type1.3 Market Analysis by Applications1.4 Market Dynamics1.4.1 Market Opportunities1.4.2 Market Risk1.4.3 Market Driving Force

2.Manufacturers Profiles

2.4.1 Business Overview2.4.2 Testosterone Replacement Therapy Type and Applications2.4.2.1 Product A2.4.2.2 Product B

3.Global Testosterone Replacement Therapy Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Testosterone Replacement Therapy Sales and Market Share by Manufacturer (2017-2018)3.2 Global Testosterone Replacement Therapy Revenue and Market Share by Manufacturer (2017-2018)3.3 Market Concentration Rate3.3.1 Top 3 Testosterone Replacement Therapy Manufacturer Market Share in 20183.3.2 Top 6 Testosterone Replacement Therapy Manufacturer Market Share in 20183.4 Market Competition Trend

4 Global Testosterone Replacement Therapy Market Analysis by Regions

4.1 Global Testosterone Replacement Therapy Sales, Revenue and Market Share by Regions4.1.1 Global Testosterone Replacement Therapy Sales and Market Share by Regions (2014-2019)4.1.2 Global Testosterone Replacement Therapy Revenue and Market Share by Regions (2014-2019)4.2 North America Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)4.3 Europe Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)4.4 Asia-Pacific Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)4.6 South America Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)4.6 Middle East and Africa Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)

6 Testosterone Replacement Therapy Market Forecast (2019-2024)6.1 Global Testosterone Replacement Therapy Sales, Revenue and Growth Rate (2019-2024)6.2 Testosterone Replacement Therapy Market Forecast by Regions (2019-2024)6.3 Testosterone Replacement Therapy Market Forecast by Type (2019-2024)6.3.1 Global Testosterone Replacement Therapy Sales Forecast by Type (2019-2024)6.3.2 Global Testosterone Replacement Therapy Market Share Forecast by Type (2019-2024)6.4 Testosterone Replacement Therapy Market Forecast by Application (2019-2024)6.4.1 Global Testosterone Replacement Therapy Sales Forecast by Application (2019-2024)6.4.2 Global Testosterone Replacement Therapy Market Share Forecast by Application (2019-2024)

6.Sales Channel, Distributors, Traders and Dealers6.1 Sales Channel6.1.1 Direct Marketing6.1.2 Indirect Marketing6.1.3 Marketing Channel Future Trend6.2 Distributors, Traders and Dealers

7. Research Findings and Conclusion

8. Appendix8.1 Methodology8.2 Data Source

Continued..

About Us:

360 Research Reports is the credible source for gaining the market reports that will provide you with the lead your business needs. At 360 Research Reports, our objective is providing a platform for many top-notch market research firms worldwide to publish their research reports, as well as helping the decision makers in finding most suitable market research solutions under one roof. Our aim is to provide the best solution that matches the exact customer requirements. This drives us to provide you with custom or syndicated research reports.

Contact Us:Name: Mr. Ajay MoreEmail: [emailprotected]Organization: 360 Research ReportsPhone: +44 20 3239 8187/ +14242530807

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Testosterone Replacement Therapy Market 2019 to 2024 With Top Countries Data : Opportunities, Industry Trends and Policies by Regions and Companies

See the article here:
Testosterone Replacement Therapy Market 2019 to 2024 With Top Countries Data : Opportunities, Industry Trends and Policies by Regions and Companies -...

Testosterone Therapy Causing Blood Clots And Health Concerns? – Video


Testosterone Therapy Causing Blood Clots And Health Concerns?
Recently the FDA began requiring warning labels on Testosterone Replacement Therapy (TRT) pharmaceutical products. Some recent studies indicate a potential risk for blood clots if you use testoster...

By: Alpha Male Medical Institute

Continue reading here:
Testosterone Therapy Causing Blood Clots And Health Concerns? - Video